386 related articles for article (PubMed ID: 23514536)
1. Galectin-9 in cancer therapy.
Fujihara S; Mori H; Kobara H; Rafiq K; Niki T; Hirashima M; Masaki T
Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):130-7. PubMed ID: 23514536
[TBL] [Abstract][Full Text] [Related]
2. Cancer Therapy Due to Apoptosis: Galectin-9.
Fujita K; Iwama H; Oura K; Tadokoro T; Samukawa E; Sakamoto T; Nomura T; Tani J; Yoneyama H; Morishita A; Himoto T; Hirashima M; Masaki T
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28045432
[TBL] [Abstract][Full Text] [Related]
3. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
[TBL] [Abstract][Full Text] [Related]
4. Possible therapeutic applicability of galectin-9 in cutaneous T-cell lymphoma.
Nakajima R; Miyagaki T; Kamijo H; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S
J Dermatol Sci; 2019 Dec; 96(3):134-142. PubMed ID: 31787505
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of Galectin-9 in human disease.
Wiersma VR; de Bruyn M; Helfrich W; Bremer E
Med Res Rev; 2013 Jun; 33 Suppl 1():E102-26. PubMed ID: 21793015
[TBL] [Abstract][Full Text] [Related]
6. Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors.
Komita H; Koido S; Hayashi K; Kan S; Ito M; Kamata Y; Suzuki M; Homma S
Oncol Rep; 2015 Oct; 34(4):2099-105. PubMed ID: 26239720
[TBL] [Abstract][Full Text] [Related]
7. Emerging Tim-3 functions in antimicrobial and tumor immunity.
Sakuishi K; Jayaraman P; Behar SM; Anderson AC; Kuchroo VK
Trends Immunol; 2011 Aug; 32(8):345-9. PubMed ID: 21697013
[TBL] [Abstract][Full Text] [Related]
8. TIM-3 does not act as a receptor for galectin-9.
Leitner J; Rieger A; Pickl WF; Zlabinger G; Grabmeier-Pfistershammer K; Steinberger P
PLoS Pathog; 2013 Mar; 9(3):e1003253. PubMed ID: 23555261
[TBL] [Abstract][Full Text] [Related]
9. Influence of Galectin-9 Treatment on the Phenotype and Function of NK-92MI Cells in the Presence of Different Serum Supplements.
Meggyes M; Nagy DU; Balassa T; Godony K; Peterfalvi A; Szereday L; Polgar B
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439744
[TBL] [Abstract][Full Text] [Related]
10. Galectin-9 in tumor biology: a jack of multiple trades.
Heusschen R; Griffioen AW; Thijssen VL
Biochim Biophys Acta; 2013 Aug; 1836(1):177-85. PubMed ID: 23648450
[TBL] [Abstract][Full Text] [Related]
11. The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy.
Yang R; Hung MC
Sci China Life Sci; 2017 Oct; 60(10):1058-1064. PubMed ID: 29027155
[TBL] [Abstract][Full Text] [Related]
12. The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer.
Yasinska IM; Sakhnevych SS; Pavlova L; Teo Hansen Selnø A; Teuscher Abeleira AM; Benlaouer O; Gonçalves Silva I; Mosimann M; Varani L; Bardelli M; Hussain R; Siligardi G; Cholewa D; Berger SM; Gibbs BF; Ushkaryov YA; Fasler-Kan E; Klenova E; Sumbayev VV
Front Immunol; 2019; 10():1594. PubMed ID: 31354733
[TBL] [Abstract][Full Text] [Related]
13. Role of Galectins in Tumors and in Clinical Immunotherapy.
Chou FC; Chen HY; Kuo CC; Sytwu HK
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
[TBL] [Abstract][Full Text] [Related]
14. Galectin-9 regulates T helper cell function independently of Tim-3.
Su EW; Bi S; Kane LP
Glycobiology; 2011 Oct; 21(10):1258-65. PubMed ID: 21187321
[TBL] [Abstract][Full Text] [Related]
15. Induction of cell adhesion by galectin-8 and its target molecules in Jurkat T-cells.
Yamamoto H; Nishi N; Shoji H; Itoh A; Lu LH; Hirashima M; Nakamura T
J Biochem; 2008 Mar; 143(3):311-24. PubMed ID: 18024965
[TBL] [Abstract][Full Text] [Related]
16. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes.
Kanzaki M; Wada J; Sugiyama K; Nakatsuka A; Teshigawara S; Murakami K; Inoue K; Terami T; Katayama A; Eguchi J; Akiba H; Yagita H; Makino H
Endocrinology; 2012 Feb; 153(2):612-20. PubMed ID: 22186414
[TBL] [Abstract][Full Text] [Related]
17. Role of galectin-8 as a modulator of cell adhesion and cell growth.
Zick Y; Eisenstein M; Goren RA; Hadari YR; Levy Y; Ronen D
Glycoconj J; 2002; 19(7-9):517-26. PubMed ID: 14758075
[TBL] [Abstract][Full Text] [Related]
18. Tim-3 Is Upregulated in NK Cells during Early Pregnancy and Inhibits NK Cytotoxicity toward Trophoblast in Galectin-9 Dependent Pathway.
Sun J; Yang M; Ban Y; Gao W; Song B; Wang Y; Zhang Y; Shao Q; Kong B; Qu X
PLoS One; 2016; 11(1):e0147186. PubMed ID: 26789128
[TBL] [Abstract][Full Text] [Related]
19. The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity.
Li Y; Feng J; Geng S; Geng S; Wei H; Chen G; Li X; Wang L; Wang R; Peng H; Han G; Shen B; Li Y
Mol Immunol; 2011 Jan; 48(4):670-7. PubMed ID: 21146220
[TBL] [Abstract][Full Text] [Related]
20. Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice.
He W; Fang Z; Wang F; Wu K; Xu Y; Zhou H; Du D; Gao Y; Zhang WN; Niki T; Hirashima M; Yuan J; Chen ZK
Transplantation; 2009 Sep; 88(6):782-90. PubMed ID: 19920777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
